Page last updated: 2024-12-05

4-methoxybiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11943
CHEMBL ID3800635
SCHEMBL ID291776
SCHEMBL ID12015212
MeSH IDM0098870

Synonyms (46)

Synonym
AC-18693
CBIOL_000842
einecs 210-339-8
hsdb 5502
brn 2043157
4-phenylanisole
nsc 3793
p-phenylanisole
ai3-00228
biphenyl, 4-methoxy
613-37-6
p-methoxybiphenyl
nsc-3793
nsc3793
wln: 1or dr
anisole, p-phenyl-
1, 4-methoxy-
4-methoxybiphenyl
4-methoxy-1,1'-biphenyl
1,1'-biphenyl, 4-methoxy-
ICCB4_000138
4-methoxybiphenyl, 97%
1-methoxy-4-phenylbenzene
4-methoxy-1
AKOS005067590
M0944
STK735568
A833171
4-methoxy-biphenyl
036wea2oud ,
unii-036wea2oud
4-06-00-04600 (beilstein handbook reference)
FT-0618931
SCHEMBL291776
4'-methoxybiphenyl
4-methoxy biphenyl
DTXSID2060620
SCHEMBL12015212
mfcd00014897
CHEMBL3800635
anisole,p-phenyl-
(s)-2-amino-2-ethyloctanoicacid
4-methoxylbiphenyl
D84255
SY049585
CS-0106689
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1306171Cytotoxicity against HEK293 cells assessed as reduction in cell growth after 3 days by MTT assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Synthesis and evaluation of biphenyl derivatives as potential downregulators of VEGF protein secretion and telomerase-related gene expressions.
AID1296577Drug level in human Caco2 cells assessed as compound level in basolateral side at 62.5 uM applied at apical compartment measured after 60 mins by LC-MS method2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
FimH Antagonists: Phosphate Prodrugs Improve Oral Bioavailability.
AID1306172Cytotoxicity against human HT-29 cells assessed as reduction in cell growth after 3 days by MTT assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Synthesis and evaluation of biphenyl derivatives as potential downregulators of VEGF protein secretion and telomerase-related gene expressions.
AID1306174Therapeutic index, ratio of IC50 for HEK293 cells to IC50 for human HT-29 cells2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Synthesis and evaluation of biphenyl derivatives as potential downregulators of VEGF protein secretion and telomerase-related gene expressions.
AID1306175Therapeutic index, ratio of IC50 for HEK293 cells to IC50 for human MCF7 cells2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Synthesis and evaluation of biphenyl derivatives as potential downregulators of VEGF protein secretion and telomerase-related gene expressions.
AID1306173Cytotoxicity against human MCF7 cells assessed as reduction in cell growth after 3 days by MTT assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Synthesis and evaluation of biphenyl derivatives as potential downregulators of VEGF protein secretion and telomerase-related gene expressions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.06 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]